Home LiteratureArticle Details
PMID: 11918081 Published · ppublish English Comparative Study Journal Article

MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines.

Clinical & experimental metastasis ·Vol. 19 ·No. 1 ·2002-00-00 ·页码 35-42

Ouatas T, Clare SE, Hartsough MT, De La Rosa A, Steeg PS

Abstract

We hypothesize that elevation of nm23-HI metastasis suppressor gene expression in micrometastatic tumor cells may reduce their subsequent colonization and invasion, and induce differentiation, with a clinical benefit. This report presents the first analysis of the nm23-HI promoter to identify sites which can increase its transcription. Deletion mapping of a 2.1 kb nm23-H1 promoter fragment tethered to a reporter gene identified three regions involved in its differential expression levels among a panel of human breast carcinoma cell lines: a 195 bp NheI-XbaI fragment responsible for basal expression levels, a 248 bp AvrII-Nhel fragment which contributed to the elevated nm23-H1 expression observed in the high expressing cell lines, and a 544 bp AvrII fragment containing an inhibitory element. Examination of the 248 bp AvrII-NheI fragment revealed the unexpected presence of three transcription factor binding sites (MAF/Ets, CTF/NF1 half site and ACAAAG enhancer) previously identified in the MMTV-LTR, and in WAP and milk gene promoters, proposed to mediate mammary-specific gene expression. Mutation of the three sites, individually or together, resulted in two-fold reductions in reporter gene expression. As controls, the same panel of mutations caused a different pattern of reporter gene expression in a non-mammary cell line, and mutation of another nearby site was without effect on nm23-HI. Our data identify a complex regulatory pattern for nm23-H1 transcription, and suggest that a mammary-specific cassette of transcription factors contribute to its elevated expression

MeSH 主题词
Binding Sites Breast Neoplasms/genetics,metabolism,pathology CCAAT-Enhancer-Binding Proteins/metabolism Carcinoma/genetics,metabolism,pathology Consensus Sequence DNA, Neoplasm/genetics Electrophoretic Mobility Shift Assay Enhancer Elements, Genetic/genetics Female Gene Expression Regulation, Neoplastic Genes, Reporter Genes, Tumor Suppressor Humans Mammary Tumor Virus, Mouse/genetics Monomeric GTP-Binding Proteins/biosynthesis,genetics Mutagenesis NFI Transcription Factors NM23 Nucleoside Diphosphate Kinases Neoplasm Metastasis/genetics Neoplasm Proteins/biosynthesis,genetics Nucleoside-Diphosphate Kinase Organ Specificity Polymorphism, Restriction Fragment Length Promoter Regions, Genetic/genetics Proto-Oncogene Proteins/metabolism Proto-Oncogene Proteins c-ets Recombinant Fusion Proteins/biosynthesis Sequence Deletion Terminal Repeat Sequences/genetics Transcription Factors/biosynthesis,genetics,metabolism Transcription, Genetic Tumor Cells, Cultured
化学物质
CCAAT-Enhancer-Binding Proteins CTF-1 transcription factor DNA, Neoplasm NFI Transcription Factors NM23 Nucleoside Diphosphate Kinases Neoplasm Proteins Proto-Oncogene Proteins Proto-Oncogene Proteins c-ets Recombinant Fusion Proteins Transcription Factors NME1 protein, human Nme1 protein, mouse Nucleoside-Diphosphate Kinase Monomeric GTP-Binding Proteins
作者与单位
共 5 位作者,点击展开单位 / ORCID
Ouatas Taoufik
Women's Cancers Section, Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892, USA. taoufik@mail.nih.gov
Clare Susan E
Hartsough Melanie T
De La Rosa Abel
Steeg Patricia S
Article Info
Journal
Clinical & experimental metastasis
Abbr.
Clin Exp Metastasis
ISSN
0262-0898
Corresponding email
Published
2002-00-00
页码
35-42
Language
English
Country/Region
Netherlands
NLM ID
8409970
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com